United Kingdom / CNBC
tirzepatide.
Headlines and brief publisher-provided excerpts about tirzepatide, with links to the original reports.
Publisher coverage
From CNBC.
REPORT / 01Recent coverage
Why Lilly and Novo are betting on amylin to power a new wave of obesity drugs after GLP-1s
Eli Lilly and Novo are developing new amylin drugs that serve as another biological lever to pull in treating obesity and diabetes.
Read the original report